m-Chlorophenylpiperazine challenge in borderline personality disorder: Relationship of neuroendocrine response, behavioral response, and clinical measures

Biological Psychiatry

Volumn 40, Issue 6, 1996, Pages 508-513

  Stein, Dan J ^a   Hollander, Eric ^b   DeCaria, Concetta M ^b   Simeon, Daphne ^b   Cohen, Lisa ^b   Aronowitz, Bonnie ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Borderline personality disorder; Compulsivity; Impulsivity; m chlorophenylpiperazine; Obsessive compulsive disorder; Serotonin

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; HYDROCORTISONE; PLACEBO; PROLACTIN; SEROTONIN;

ADULT; ARTICLE; BEHAVIOR; BORDERLINE STATE; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; FEMALE; HUMAN; IMPULSIVENESS; MALE; ORAL DRUG ADMINISTRATION; PERSONALITY DISORDER; PRIORITY JOURNAL;

EID: 0030587418     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00470-X     Document Type: Article

References (31)

1. Benkelfat C, Murphy DL, Hill JL, et al (1991): Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:383.
2. Brown G, Goodwin F, Ballenger J, et al (1979): Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1:131-139.
3. Buss AH, Durkee A (1951): An inventory for assessing different kinds of hostility. J Consult Clin Psychology 21:343-348.
4. Cloninger CR (1987): A systematic method for clinical descriptions and classification of personality variants. Arch Gen Psychiatry 44:573-588.
5. Coccaro EF, Siever LJ, Klar HM, et al (1989): Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46:587-599.
6. Coccaro EF, Astill JL, Herbert J, et al (1990): Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. J Clin Psychopharmacol 10:373-375.
7. Coccaro EF, Harvey PD, Kupsaw-Lawrence E, Herbert JL, Bernstein DP (1991): Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior. J Neuropsychiatry 3(suppl):44-51.
8. Cornelius JR, Soloff PH, Perel JM, Ulrich RF (1989): Fluoxetine trial in borderline personality disorder. Presented at the 142nd Annual Meeting of the American Psychiatric Association, San Francisco, CA.
9. Depeu RA, Spoont MR (1986): Conceptualizing a serotonin trait: a behavioral dimension of constraint. In Mann JJ, Stanley M (eds), Psychobiology of Suicidal Behavior. New York: New York Academy of Science.
10. Hamik A, Peroutka SJ (1989): 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry 25:569-575.
11. Hamilton M (1959): The assessment of anxiety by rating. Br J Med Psychol 32:50-55.
12. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
13. Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JB, Klein DF, Liebowitz MR (1992): Serotonergic function in obsessive-compulsive disorder: Behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49:21-28.
14. Hollander E, Stein DJ, DeCaria CM (1993): Impulsivity and compulsivity: Symptoms and diagnoses. International Psychiatry Today 1:11-12.
15. Hollander E, Stein DJ, DeCaria CM, Cohen L, Saoud JB, Skodol AE, Kellman D, Rosnick L, Oldham J (1994): Serotonergic sensitivity in borderline personality disorder: Preliminary findings. Am J Psychiatry 151:277-280.
16. Kahn RS, Wetzler S, van Praag HM, Asnis GM, Strauman T (1989): Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res 25:101-104.
17. Markovitz PJ, Calabrese JR, Schulz SC, et al (1991): Fluoxetine in the treatment of borderline and schizotypal personality disorder. Am J Psychiatry 148:1064-1067.
18. Markowitz PI, Coccaro EF (1995): Biological challenge studies of impulsivity, aggression, and suicidal behavior. In Hollander E, Stein DJ (eds), Impulsivity and Aggression. New York, NY: John Wiley.
19. McGlashan TH (1992): The longitudinal profile of borderline personality disorder: Contributions from the Chestnut-Lodge follow-up study. In Silver D, Rosenbluth M (eds), Handbook of Borderline Disorders. Madison, CT: International Universities Press.
20. Moss HB, Yao JK, Panzak L (1990): Serotonergic responsivity and behavioral dimensions in antisocial personality disorder with substance abuse. Biol Psychiatry 28:325-338.
21. Munaro NI (1978): The effect of ovarian steroids on hypothalamic 5-hydroxytryptamine neuronal activity. Neuroendocrinology 26:270-276.
22. Myers JE, Mieckzkowski T, Perel J, Abbondanza D, Cooper TB, Mann JJ (1994): Abnormal behavioral responses to fenfluramine in patients with affective and personality disorders: Correlation with increased serotonergic responsivity. Biol Psychiatry 35:112-120.
23. Norden MJ (1989): Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 13:885-893.
24. O'Keane V, Moloney E, O'Neill H, O'Connor A, Smith C, Dinan TG (1992): Blunted prolactin responses to d-fenfluramine in sociopathy: Evidence for subsensitivity of central Serotonergic function. Br J Psychiatry 160:643-646.
25. Soubrie P (1986): Reconciling the role of central serotonin neurones in human and animal behavior. Behav Brain Sci 9:319-364.
26. Stanley M, Mann JJ (1988): Biological factors associated with suicide, In Frances AJ, Hales RE (eds), Review of Psychiatry. Washington DC: American Psychiatric Press.
27. Stone M (1992): Borderline personality disorder: Course of illness. In Clarkin JF, Marziali E, Munroe-Blum H (eds), Borderline Personality Disorder: Clinical and Empirical Perspectives. New York: Guilford Press.
28. Stein DJ, Hollander E (1993): The spectrum of obsessive-compulsive related disorders. In Hollander E (ed), Obsessive-Compulsive Related Disorders. Washington DC: American Psychiatric Press.
29. Stein DJ, Hollander E, Liebowitz MR (1993): Neurobiology of impulsivity and impulse control disorders. J Neuropsychiatry Clin Neuroscience 5:9-17.
30. Wetzler S, Kahn RS, Asnis GM, Korn M, Van Praag HM (1991): Serotonin receptor sensitivity and aggression. Psychiatry Res 37:271-279.
31. Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987): Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44:946-951.